Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells

International Journal for Parasitology

Volumn 34, Issue 1, 2004, Pages 15-25

  Hansen, Diana S ^a   Schofield, Louis ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

CD1d restricted NKT cells; Glycolipid antigens; Immunity; Infectious diseases; Pathogenesis

Indexed keywords

CD1D ANTIGEN;

IMMUNITY; INFECTIOUS DISEASE;

BACTERIAL INFECTION; CELL ACTIVITY; CELL FUNCTION; CHAGAS DISEASE; CRYPTOCOCCUS NEOFORMANS; HELMINTH; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; LEISHMANIA MAJOR; LISTERIA MONOCYTOGENES; MALARIA; MOLECULAR DYNAMICS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NATURAL KILLER CELL; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM YOELII; PROTOZOAL INFECTION; REVIEW; SALMONELLA; SCHISTOSOMA MANSONI; T LYMPHOCYTE; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI; VIRUS INFECTION; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0347357681     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2003.09.007     Document Type: Review

References (79)

1. Apostolou I., Takahama Y., Belmant C., Kawano T., Huerre M., Marchal G., Cui J., Taniguchi M., Nakauchi H., Fournie J.J., Kourilsky P., Gachelin G. Murine natural killer T (NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA. 96:1999;5141-5146.
2. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:1996;2391-2396.
3. Baron J.L., Gardiner L., Nishimura S., Shinkai K., Locksley R., Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 16:2002;583-594.
4. + T cells. Nature. 372:1994;691-694.
5. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1999;1973-1980.
6. Berendt A.R., Simmons D.L., Tansey J., Newbold C.I., Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion molecule for Plasmodium falciparum. Nature. 341:1989;57-59.
7. Biron C.A., Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:2001;458-464.
8. - thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178:1993;901-908.
9. + T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184:1996;1295-1304.
10. Carnaud C., Lee D., Donnars O., Park S.-H., Beavis A., Koezuka Y., Bendelac A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:1999;4647-4650.
11. Chackerian A., Alt J., Perera V., Behar S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70:2002;6302-6309.
12. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H., Dautry-Varsat A., Bendelac A. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189:1999;103.
13. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051-1066.
14. + effector function against intracellular infection. J. Exp. Med. 184:1996;131-139.
15. Duthie M.S., Kahn S.J. Treatment with a-galactoxylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168:2002;5778-5785.
16. Duthie M.S., Wleklinski-Lee M., Smith S., Nakayama T., Taniguchi M., Kahn S.J. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol- modified surface protein. Infect. Immun. 70:2002;36-48.
17. Eberl G., MacDonald H.R. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:2000;985-992.
18. + T cells upon NK T or T cell activation. J. Immunol. 165:2000;4305-4311.
19. + TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur. J. Immunol. 25:1995;3321-3325.
20. + natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 29:1999;650-659.
21. + T cells producing IL-4 may be involved in the increased susceptibility of mice with the beige mutation during Salmonella infection. J. Immunol. 158:1997;2268-2277.
22. Exley M.A., Bigley N.J., Cheng O., Tahir S.M., Smiley S.T., Carter Q.L., Stills H.F., Grusby M.J., Koezuka Y., Taniguchi M., Balk S.P. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69:2001;713-718.
23. Faveeuw C., Angeli V., Fontaine J., Maliszewski C., Capron A., Van Kaer L., Moser M., Capron M., Trottein F. Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J. Immunol. 169:2002;906-912.
24. Gansert J.L., Kiessler V., Engele M., Wittke F., Rollinghoff M., Krensky A.M., Porcelli S.A., Modlin R.L., Stenger S. Human NKT cells express granulysin and exhibit antimycobacterial activity. J. Immunol. 170:2003;3154-3161.
25. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., Taniguchi M., Bendelac A., Van Kaer L., Koezuka Y., Tsuji M. alpha-Galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA. 97:2000;8461-8466.
26. Grant E.P., Degano M., Rosat J.P., Stenger S., Modlin R.L., Wilson I.A., Porcelli S.A., Brenner M.B. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189:1999;195-205.
27. Grau G.E., Fajardo L.F., Piguet P.F., Allet B., Lambert P.H., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 237:1987;1210-1212.
28. Grau G.E., Heremans H., Piguet P.F., Pointaire P., Lambert P.H., Billiau A., Vassalli P. Monoclonal antibody against interferon γ can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 86:1989;5572-5574.
29. Grubor-Bauk B., Simmons A., Mayrhofer G., Speck P.G. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. J. Immunol. 170:2003;1430-1434.
30. Grzych J.M., Pearce E., Cheever A., Caulada Z.A., Caspar P., Heiny S., Lewis F., Sher A. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1991;1322-1327.
31. Guinet F., Ronet C., Mempel M., Huerre M., Carniel E., Gachelin G. NKT cells-containing inflammatory lesions induced by Yersinia pseudotuberculosis glycolipids. Immunol. Lett. 80:2002;113-118.
32. Gumperz J.E., Brenner M.B. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13:2001;471-478.
33. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:2002;625-636.
34. Hansen D.S., Siomos M.A., Buckingham L., Scalzo A.A., Schofield L. Regulation of murine malarial pathogenesis by CD1d-restricted NKT cells and the Natural Killer Complex. Immunity. 18:2003;391-402.
35. Hansen D.S., Siomos M.A., de Koning-Ward T.F., Buckingham L., Crabb B.S., Schofield L. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 33:2003;2588-2598.
36. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:1989;59-72.
37. Hobbs J.A., Cho S., Roberts T.J., Sriram V., Zhang J., Xu M., Brutkiewicz R.R. Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J. Virol. 75:2001;10746-10754.
38. + V alpha 14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:2000;1267-1274.
39. Jennings V.M., Actor J.K., Lal A.A., Hunter R.L. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 65:1997;4883-4887.
40. - T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production. Immunology. 91:1997;511-519.
41. Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:2000;921-930.
42. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:2000;105-114.
43. Kawakami K., Kinjo Y., Uezu K., Yara S., Miyagi K., Koguchi Y., Nakayama T., Taniguchi M., Saito A. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167:2001;6525-6532.
44. Kawakami K., Kinjo Y., Yara S., Koguchi Y., Uezu K., Nakayama T., Taniguchi M., Saito A. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69:2001;213-220.
45. Kawakami K., Kinjo Y., Uezu K., Yara S., Miyagi K., Koguchi Y., Nakayama T., Taniguchi M., Saito A. Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol. Immunol. 46:2002;207-210.
46. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., Koseki H., Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
47. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Sato H., Kondo E., Harada M., Koseki H., Nakayama T., Tanaka Y., Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc. Natl. Acad. Sci. USA. 95:1998;5690-5693.
48. Lucas M., Gadola S., Meier U., Young N.T., Harcourt G., Karadimitris A., Coumi N., Brown D., Dusheiko G., Cerundolo V., Klenerman P. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J. Virol. 77:2003;2251-2257.
49. Minton K. Can an NKT cell change its spots? Nat. Rev. Immunol. 3:2003;356-357.
50. Miyahira Y., Katae M., Takeda K., Yagita H., Okumura K., Kobayashi S., Takeuchi T., Kamiyama T., Fukuchi Y., Aoki T. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect. Immun. 71:2003;1234-1241.
51. Molano A., Park S.H., Chiu Y.H., Nosseir S., Bendelac A., Tsuji M. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 164:2000;5005-5009.
52. + alpha beta T cells in IL-12 production during Salmonella infection. J. Immunol. 163:1999;2057-2063.
53. Nishimura T., Kitamura H., Iwakabe K., Yahata T., Ohta A., Sato M., Takeda K., Okumura K., Van Kaer L., Kawano T., Taniguchi M., Nakui M., Sekimoto M., Koda T. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 7:2000;987-994.
54. Pearce E.J., Caspar P., Grzych J.M., Lewis F.A., Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 173:1991;159-166.
55. - NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164:2000;1463-1469.
56. Porcelli S.A. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1995;1-98.
57. - T lymphocytes to a microbial antigen. Nature. 360:1992;593-597.
58. Procopio D.O., Almeida I.C., Torrecilhas A.C., Cardoso J.E., Teyton L., Travassos L.R., Bendelac A., Gazzinelli R.T. Glycosylphosphatidylinositol- anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 169:2002;3926-3933.
59. r mouse: a strain congenic for Cmv1 and the NK gene complex. Immunogenetics. 41:1995;148-151.
60. Schofield L., Ferreira A., Altszuler R., Nussenzweig V., Nussenzweig R.S. Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol. 139:1987;2020-2025.
61. + T cells and antibodies required for immunity to malaria sporozoites. Nature. 330:1987;664-666.
62. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Grusby M.J., Tachado S.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 283:1999;225-229.
63. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., Bloom B.R., Brenner M.B., Kronenberg M., Brennan P.J., Modlin R.L. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269:1995;227-230.
64. Sieling P.A., Porcelli S.A., Duong B.T., Spada F., Bloom B.R., Diamond B., Hahn B.H. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J. Immunol. 165:2000;5338-5344.
65. Spence P.M., Sriram V., Van Kaer L., Hobbs J.A., Brutkiewicz R.R. Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. Immunology. 104:2001;168-174.
66. Stenger S., Niazi K.R., Modlin R.L. Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J. Immunol. 161:1998;3582-3588.
67. Sugawara I., Yamada H., Mizuno S., Li C.Y., Nakayama T., Taniguchi M. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis. 82:2002;97-104.
68. Swain S.L. IL4 dictates T-cell differentiation. Res. Immunol. 144:1993;616-620.
69. Tangri S., Brossay L., Burdin N., Lee D.J., Corr M., Kronenberg M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc. Natl. Acad. Sci. USA. 95:1998;14314-14319.
70. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., Wittner M. Chagas' disease. Clin. Microbiol. Rev. 5:1992;400-419.
71. + NKT cells during HIV type 1 infection. J. Immunol. 168:2001;1490-1495.
72. van Dommelen S.L., Tabarias H.A., Smyth M.J., Degli-Esposti M.A. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77:2003;1877-1884.
73. White N.J., Ho M. The pathophysiology of malaria. Adv. Parasitol. 31:1992;83-173.
74. + T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. J. Immunol. 163:1999;3083-3091.
75. + CTLs in vivo. J. Immunol. 155:1995;2564-2570.
76. Yokoyama W.M., Plougastel B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:2003;304-316.
77. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1994;1285-1295.
78. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., Cooke A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33:2003;1439-1449.
79. Zeng D., Lee M.K., Tung J., Brendolan A., Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164:2000;5000-5004.